Question : INCREASE IN THE DRUG RETAIL PRICES



(a) whether the Pharma Industry has urged the Government to allow increase of 3 to 4% on drug retail prices and to introduce tamper proof packaging on medicines as reported in the ‘Times of India’ dated August 21, 2007;

(b) if so, the details thereof;

(c) whether the Pharma Industry has also urged the Government to adopt stringent measures for sanctioning of manufacturing license to the drug manufacturers; and

(d) if so, the reaction of the Government thereto?

Answer given by the minister


MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS AND MINISTER OF STATE IN THE MINISTRY OF PARTLIAMENTARY AFFIRS (SHRI B.K. HANDIQUE)

(a) to (d): Yes, Sir. M/s. Nicholas Piramal India Limited represented to this Department in July, 2007 expressing its concern on the issue of menace of spurious drugs in the country and has given some suggestions to this Department viz, grant of higher Maximum Allowable Post Manufacturing Expenses (MAPE) under DPCO for pilfer proof packaging, review of laws and regulations governing the allotment of manufacturing licenses, revocation of licenses of spurious drug manufacturers etc, in order to tackle this problem. Since quality of drugs comes under the purview of Drugs and Cosmetics Act, 1940 administered by the Ministry of Health and Family Welfare, that Ministry has been requested to look into this issue. Regarding grant of higher MAPE to introduce tamper proof packaging of medicines the matter is being examined by this Department.